Skip to content

Non-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021

Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.

Read More

Cancer Advocacy Conversation

The purpose of this event is for advocates and those impacted with cancer to dial in to learn about cancer advocacy efforts, how to be an effective advocate, promote key legislation, build grassroots community and support for advocates new to the process. We aim to build a long-term cancer advocacy support system and efficacy and would be honored to have you join us.

Read More

Non-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021

Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.

Read More

Non-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021

Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.

Read More

Non-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021

Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.

Read More

Non-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021

Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.

Read More

Non-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021

Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.

Read More

Non-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021

Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.

Read More

Non-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021

Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.

Read More